Smac, (second mitochondrial activator of caspases), is released from the mitochondria during apoptosis to relieve inhibition of caspases by the IAPs (Inhibitor of Apoptosis Proteins).
Introduction
Apoptosis (programmed cell death) plays key roles in both normal development and pathophysiology. Given the central importance of programmed cell death, apoptotic pathways are highly regulated, containing many checkpoints. Failures of regulatory checkpoints are pathogenic, the effects of which range from neurodegeneration to cancer (1, 2) .
Apoptosis proceeds by two major signaling pathways, known as the "intrinsic" (mitochondrial) and "extrinsic" (death receptor) pathways. One early event in mitochondrialmediated apoptosis is the activation of the Bcl-2 family of proteins (3) . They are important in controlling the release of regulatory mitochondrial proteins, which are sequestered in the mitochondrial intermembrane space 1 (IMS) until signaled. There is substantial debate about the mechanisms for release of mitochondrial proteins in apoptosis (3) (4) (5) .
When apoptosis is initiated, Smac in its processed form of 184 amino acids (21 kDa) is released from the mitochondria to interact with various IAPs, including XIAP, c-IAP1, and ML-IAP (6) (7) (8) . Smac performs its function of antagonizing XIAP by competing for the same binding site as that of caspase-9 on the BIR3 domain of XIAP, as well as binding to the linker peptide between the BIR1 and BIR2 domains, sterically inhibiting access to the caspase-3 and -7 binding site (9) .
The detailed mechanism of Smac's translocation from the mitochondria to the cytosol remains unknown and the kinetics of Smac release from a single cell have not been measured.
While the specific Bcl-2 family members which cause the release of mitochondrial proteins remain controversial, one key question is: do Smac, cytochrome c and other mitochondrial proteins exit the mitochondria on the same time scale and via the same pathway? Studies on cell populations indicate that Smac and cyt. c exit the mitochondria on the same general time scale, and a single transport mechanism has been suggested. However, such studies are not sufficiently sensitive to resolve the temporal relationship between cyt. c and Smac release or address the duration of release in individual cells undergoing apoptosis. In several experiments, cyt. c release is shown to be caspase independent, while the release of Smac is not (10, 11) . This has led some researchers to suggest that Smac release may be a downstream event of cyt. c release. A single cell analysis of cytochrome-c-GFP stably expressed in HeLa cells has been performed by Goldstein et al. and the kinetics of this proteins release characterized (12) . Here, we report a detailed kinetic analysis of the release of Smac-EYFP from the mitochondria into the cytosol of individual HeLa cells. These data allow direct comparisons of cyt. c and Smac transport kinetics, and thereby can probe whether a single mechanism describes transport of both proteins.
Experimental Procedures.

Generation of the recombinant plasmid pSmac-EYFP
The creation of a fusion protein between Smac and the fluorescent protein EYFP was chosen as the method for studying the kinetics of Smac's apoptotic release from the mitochondria. The plasmid pEYFP-N1 (Clontech) were used to perform the subcloning.
The plasmid pcDNA3.1(-) (Invitrogen) with full-length Smac inserted between the XhoI and BamHI sites in the multiple cloning site was a gift from Prof. Yigong Shi and was used as the template for the described PCR reaction. Primers, Smac1 and Smac2 (Keystone Labs), were chosen to anneal 5' and 3' ends of the full-length Smac gene in the plasmid pcDNASmac3.1(-).
The primers were engineered to include XhoI and BamHI sites, respectively, which were employed in later steps of the subcloning procedure. Biotin tags were also included to provide an easy assay for completion of restriction digestion.
A PCR reaction with Smac1, Smac2 and pcDNASmac3.1(-) as the template was performed under the following conditions: 1x 94°C for 1min, 25 x (94°C for 1min; 48°C for 90 sec; 72°C for 90 sec), 1 x 72°C for 10min). Amplification of the target sequence of the correct size was confirmed by gel electrophoresis. The PCR product was subjected to restriction digestion with XhoI and BamHI. The DNA was digested with HK Phosphatase (Epicentre Technologies). The digested Smac fragment was ligated to digested pEYFP-N1 using T4 DNA ligase (Epicentre Technologies) overnight at 16°C. The resulting plasmid was transformed into the E. coli strain XL2-Blue (Stratagene) and transformants were selected on medium containing 30µg/mL Kanamycin. The correct DNA sequence was confirmed using DNA sequencing analysis.
Generation of a stable cell line expressing Smac-EYFP
The plasmid pSmac-EYFP was transfected into HeLa cells using GenePORTER (Gene Therapy Systems, San Diego, CA). Cells were analyzed for fluorescence 48 hours posttransfection under a fluorescence microscope. All cells were incubated at 37°C, 5 % CO 2 .
Geneticin (Gibco) was added to the medium at a concentration of 1mg/mL. Over three days, geneticin was diluted to a final concentration of 100 µg/mL. Surviving cells were grown for 1 week, and one part of the cell population was seeded into 96 well plates at a density of 0. Twenty-four hours before imaging, cells were plated to a black covered 15mm Delta T culture dish (Bioptechs) and grown overnight at 37°C under a 5% CO 2 atmosphere to be 50% confluent at the time of imaging. Cells were washed in phenol-red free DMEM supplemented with 25mM HEPES and 10% FCS. The dish was inserted into the stage adapter (Delta T Stage
Adapter, Bioptechs). Cells were treated with staurosporine (2.14 µM). The experimental conditions were held constant at 37ºC with a 5% CO 2 atmosphere for the entire imaging period.
Time sequences were collected by taking five optical slices at a 2 µm interval once every two minutes. Imaging and cell preparation was identical for a control data set, where no staurosporine was added to the cells. Images were analyzed using the LSM 510 software (v2.8)
by projecting optical slices using maximum intensity mode.
Results
Characterization of HeLa cell line stably expressing Smac-EYFP.
To examine the translocation kinetcs of Smac from the mitochondria to the cytosol, we (6), is localized in the mitochondria (see Figure 1 ).
In the Smac-EYFP cell line created, a minority of the cells expressed the fusion protein at observable levels. To increase the probability of observing a release event the fluorescent cells were enriched using fluorescence activated cell sorting. After sorting, ~90% of the cells fluoresced and exhibited a punctate pattern of emission emanating from the mitochondria.
Ordering of Smac Release Relative to other Apoptotic Markers
During apoptosis, characteristic changes to the cellular structure occur. These include:
cell shrinkage, membrane blebbing, changes to the plasma membrane structure, chromatin condensation and fragmentation of nuclear DNA (13) . We sought to establish the order of Smac-EYFP release among some other apoptotic events. Thus, on a population of cells, we 
Single Cell Kinetics of Smac-EYFP Translocation
Upon translocation of Smac-EYFP to the cytosol, the pattern of fluorescence changes from punctate to diffuse corresponding with a change in effective concentration of the fluorophore from high to low (see Figure 3a) . Using time resolved confocal microscopy, this translocation event was monitored in live cells in real time. In each experiment, a field of cells was monitored at 37 o C and 5% CO 2 . The apoptotic stimuli used was staurosporine (2.14 µM), a well known kinase inhibitor that induces programmed cell death via the mitochondrial pathway (14) . In three separate experiments, multiple cells were observed releasing Smac-EYFP.
The length of each experiment ranged from 3-6 hours with pre-incubation of the cells for 1-2 hours before imaging began. Five optical slices that span the depth of the cell were imaged every two minutes. The optics were optimized so that photobleaching was negligible over the course of the experiments. The projected fluorescence along the z-axis was used for analysis. 
Discussion
The release of pro-apoptotic factors from the mitochondria is a key step in a cell's final commitment to cell death. Despite this, the detailed mechanism(s) for the release of Smac (and other pro-apoptotic mitochondrial proteins) remains unknown. In addition, whether proapoptotic factors such as Smac and cytochrome c translocate via the same pathway is not known.
Smac release provides the fatal blow of the "Cyt. c-Smac punch", thus the idea that their release may be coupled is reasonable (15) . However, whether or not such an event is in fact coordinated is not known. Some studies indicate that cyt. c and Smac exit the mitochondria at the same time (10, 16) , but these are a result of population rather than single cell analyses, and thus cannot accurately assess the temporal ordering of events in individual cells.
In this work, we have determined that the translocation of Smac (tagged with the fluorescent protein EYFP) from the mitochondria to the cytosol of HeLa cells occurs in 19 + 3 minutes. Previous work by Goldstein et al. reported(12) that in HeLa cells undergoing apoptosis, the duration of cyt c-GFP release is 5 + 2.5 minutes (see Figure 3c) . Thus, our results
show that Smac release does not occur on the same time scale as cytochrome c release in this cell type. While cyt. c-GFP release is rapid and complete, the release of Smac-EYFP requires nearly four times as long and its release is frequently only 60-80% complete. These data would suggest that the mechanism for Smac translocation may be different from that for cyt. c release. Whether commencement of cyt c and Smac release is coincident in each cell undergoing apoptosis cannot be ascertained here; however, microscopy experiments to test whether or not this is the case are underway.
Evidence supporting the idea that Smac and cyt. Contrary to this idea, new results indicate that the Bcl-2 family could be involved in the direct activation of caspases, such as caspase-2, prior to the release of mitochondrial proteins (17) (18) (19) (20) . For instance, caspase-2 activity is found to occur upstream of mitochondrial release of cyt.
c or Smac in cell stress related apoptosis (19, 20) . Given the differences in size and shape of Smac and cyt. c, it is necessary to consider the possibility that these proteins diffuse through the same pore, but the kinetic of diffusion for the larger, elongated Smac dimer are retarded. Simple diffusion models where cyt. c is considered a sphere and the Smac dimer a prolate ellipsoid cannot account for the fourfold difference in difference in the translocation kinetics of cyt. c and Smac. 2 Based on electrophysiological data, Tsujimoto (22) proposed a novel Bax-VDAC channel has a pore size of approximately 120 Å.
According to our calculation for diffusion through an orifice of a heterogeneous medium(23), release through this size channel would only marginally affect the rate of Smac release relative to that of cyt. c. Solid evidence supporting a particular pore size for the proposed "Bax-only" channels does not exist, making more detailed calculations for this case less meaningful. Such models, while oversimplified, provide an indication that the translocation kinetics of Smac suggest a distinctly different release mechanism for Smac than for cytochrome c.
Several researchers have found that cyt. c release precedes mitochondrial depolarization.
Madesh et al. observed that substantial tBid induced cyt. c release begins before the onset of mitochondrial depolarization in permeabilized HepG2 cells (16) . In another study involving live HeLa cells, loss of mitochondrial transmembrane potential, ∆Ψm, was found to require at least 12 minutes, and begins after a significant fraction of cyt. c has been released (24) . Given these results and other experimental evidence(12), a mechanism for cyt. c release that is distinct from a permeability transition has been widely argued. It will be interesting to determine whether or not Smac release precedes, coincides or occurs after mitochondrial depolarization in HeLa cells.
Such experiments are in progress.
Currently, there is no evidence to suggest that Smac release should precede cyt. c release.
Here, we show that in HeLa cells the time required for Smac release is four times that measured for cyt. c release. In two separate studies (16, 24) , mitochondrial depolarization began after (but within 5 minutes) of the onset of cyt. c release and required ~12 minutes. Thus, given the current measurements of Smac efflux, it appears that Smac release, requiring 19 + 3 minutes, occurs during or after mitochondrial depolarization. 16 2. This model might be expected to prevail in the case of efflux through large pores of the type expected when a permeability transition occurs. 
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